Patient First: Enhancing Strategies for Effective Patient Engagement, Recruitment and Diversity in Clinical Trials

Life Sciences, Clinical Trials, Pharmaceutical Regulation, Patient Recruitment & Retention,
  • Thursday, September 19, 2024

Webinar Preview

In this thought-provoking webinar, the speakers will delve into the crucial aspects of patient engagement, recruitment and diversity within the healthcare industry. This webinar aims to shed light on effective strategies and offer valuable insights into the challenges faced in these areas.

The primary focus of this webinar will be on patient recruitment strategies, exploring innovative approaches to reduce participation burden and drive retention and diversity. They will also delve into the transformative changes occurring in patient access and recruitment, as well as the evolving nature of patient interaction with researchers.

Additionally, they will explore the ‘new wave’ of industry giving back into patient communities, both online and in-person, and how they contribute to fostering a collaborative environment whilst increasing awareness and successful recruitment. This webinar will also address the critical topic of diversity, highlighting the significance of recruiting patients from underrepresented populations. They will also examine the new US Food and Drug Administration (FDA) guidance in this regard and discuss strategies to effectively engage and recruit patients from these demographics.

Finally, they will be discussing the future. By examining current trends and anticipating future developments, the expert speakers aim to provide attendees with valuable insights and actionable strategies to navigate the ever-changing landscape of patient-first research.

Don’t miss this opportunity to learn from industry experts and gain a competitive edge in the evolving landscape of clinical research.

Register now for this engaging webinar and discover how site and patient-first strategies drive successful patient recruitment and foster diversity in clinical trials. 

Speakers

Dr. Christina Kyriakidou, AES

Dr. Christina Kyriakidou, Executive Director, Medical Operations, EMEA sites, Accelerated Enrollment Solutions

Dr. Christina Kyriakidou completed her studies in engineering and later in medicine in the United Kingdom. She worked as a Doctor for the National Health Service, specializing in Anesthesia and Intensive Care Medicine.

She moved to clinical research seven years ago, starting at Synexus Midlands where she worked as a Principal Investigator for studies across several therapeutic areas, including cardiometabolic diseases, respiratory, GI and vaccines.

In 2022, she became the Director of Med Ops for the UK sites, before taking up the Executive Director role for the EMEA region later this year.

Message Presenter
Tim Rich, PPD clinical research business of Thermo Fisher Scientific

Tim Rich, Vice President, Global Head of Patient First Recruitment & Strategy, PPD clinical research business of Thermo Fisher Scientific

Over the last 20+ years, Tim Rich has held a range of leadership positions across operations, corporate strategy and has been a founding member of several PPD business units. Throughout, he has been an instrumental strategic leader focused on organizational growth, innovation and successful business delivery anchored on a focus of progressing solutions that increase patient access and decrease the burden of research participation.

Tim is currently the Vice President and Global Head of Patient First Recruitment & Strategy. Patient First Recruitment and Strategy is focused on making it easier to find, enroll and retain patients and is supported by three segments: decentralized trial solutions, site-enabling and patient-facing technology and patient recruitment solutions. All segments are digitally enabled, human-centered and focused on reaching the patient where they are.

Message Presenter
Rose Blackburne, PPD clinical research business, Thermo Fisher Scientific

Dr. Rose Blackburne, MD, MBA, Vice President, Global Head of General Medicine & Women’s Health, PPD clinical research business of Thermo Fisher Scientific

Dr. Rose Blackburne, MD, MBA, is Vice President and Global Head of General Medicine & Women’s Health at PPD, the Clinical Research Group of Thermo Fisher Scientific. In her role, she has strategic input and oversight for a portfolio of pharmaceutical and medical device product development opportunities across therapeutic areas including women’s health, nephrology, GI, dermatology and urology.

Dr. Blackburne is a globally recognized leader in medical product development and has been instrumental in numerous approvals for pharmaceuticals, vaccines, medical devices and diagnostic tests. She is a thought leader in health equity and diversity in clinical research.

Read more...

Since 2016, Dr. Blackburne has served on the FDA Patient Engagement Advisory Committee (PEAC) part of FDA’s Patient Focused Drug Development initiatives. She was appointed by the FDA Commissioner to provide advice on issues relating to the regulation of medical devices and their use by patients and to develop the agency’s guidance and policies. She was a recipient of the 2024 Top Blacks in Health Care Award from BlackDoctors.org as well as the 2024 W. Montague Cobb National Health Award for Leadership and Excellence in Health Equity.

Based in Washington, DC, Dr. Blackburne is board-certified in Obstetrics and Gynecology with over 25 years of experience in healthcare. She was a practicing Ob/Gyn physician and PI for clinical trials prior to her career in the pharma/biotech clinical research industry.

Dr. Blackburne has 20 years of clinical research and development experience and has held numerous CRO Global leadership positions across therapeutic areas and Ph I-IV programs. She has a passion for health equity and women’s health policies and leads numerous initiatives focused on improving inclusion of underrepresented populations in clinical trials. This expertise is evidenced by her numerous publications focused on diversity in clinical trials, health equity and women’s health.

Dr. Blackburne received her medical degree at the Morehouse School of Medicine, Atlanta, Georgia, and completed an Obstetrics and Gynecology residency at Columbia University in New York. She holds a Master of Business Administration from the Darden Graduate School of Business at the University of Virginia. She has also studied Health Policy and Health Care Delivery at Harvard University John F. Kennedy School of Government and completed her BA at University of Virginia, Charlottesville, Virginia.

Read Less...

Message Presenter

Who Should Attend?

This webinar is designed for professionals and stakeholders involved in the clinical research industry, including:

  • Clinical Research Coordinators/Clinical Trial Managers, and other professionals involved in the planning, execution and management of clinical trials
  • Investigators/Site Coordinators
  • Site personnel responsible for patient recruitment and engagement at clinical trial sites
  • Professionals involved in patient recruitment and retention strategies, including those working in patient recruitment agencies, patient advocacy groups and clinical trial marketing
  • Professionals responsible for ensuring compliance with regulatory requirements and guidelines in clinical trials

What You Will Learn

Attendees will learn about:

  • Innovative approaches to tailor recruitment efforts to prioritize patient needs and preferences, resulting in improved engagement and recruitment rates
  • Imperative changes needed in research and participant engagement to empower patients
  • Common challenges faced by sites and researchers and explore potential solutions to optimize patient engagement and recruitment strategies
  • Benefits of decentralized strategies that leverage technology to minimize travel requirements, improve convenience and enhance patient retention, diversity and engagement
  • Importance of diversity in patient populations and explore strategies to improve representation from underrepresented groups

Xtalks Partner

PPD clinical research business of Thermo Fisher Scientific Inc.

The PPD clinical research business of Thermo Fisher Scientific Inc., the world leader in serving science, enables customers to accelerate innovation and increase drug development productivity. Utilizing patient-centered strategies and data analytics, their capabilities cover multiple therapeutic areas and include early development, all phases of clinical development, peri- and post-approval, novel approaches to patient recruitment and investigator sites, and comprehensive laboratory services. Recognized as a global industry leader in accelerating promising medicines from early development through regulatory approval and market access, they serve pharma, biotech, medical device and government organizations with custom-tailored solutions, including full-service partnerships and functional service partnerships. As a strategic partner in clinical development and analytical services, they apply cutting edge technologies, therapeutic expertise and a firm commitment to quality to help customers deliver life-changing therapies.

You Must Login To Register for this Free Webinar

Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.

Create Account